These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28194003)

  • 1. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [
    Collste K; Plavén-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; ; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
    Mol Psychiatry; 2017 Jun; 22(6):850-856. PubMed ID: 28194003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
    Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
    Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [
    Selvaraj S; Bloomfield PS; Cao B; Veronese M; Turkheimer F; Howes OD
    Schizophr Res; 2018 May; 195():206-214. PubMed ID: 28893493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [
    Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Olgart Höglund C; Kosek E
    J Neuroimmunol; 2019 Sep; 334():577000. PubMed ID: 31260948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and reliability of [
    Plavén-Sigray P; Schain M; Zanderigo F; ; Rabiner EA; Gunn RN; Ogden RT; Cervenka S
    Neuroimage; 2019 Mar; 188():102-110. PubMed ID: 30500425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.
    Albrecht DS; Forsberg A; Sandström A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Höglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
    Brain Behav Immun; 2019 Jan; 75():72-83. PubMed ID: 30223011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.
    Dahoun T; Calcia MA; Veronese M; Bloomfield P; Reis Marques T; Turkheimer F; Howes OD
    Brain Behav Immun; 2019 Aug; 80():742-750. PubMed ID: 31112791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation.
    Kreisl WC; Jenko KJ; Hines CS; Lyoo CH; Corona W; Morse CL; Zoghbi SS; Hyde T; Kleinman JE; Pike VW; McMahon FJ; Innis RB;
    J Cereb Blood Flow Metab; 2013 Jan; 33(1):53-8. PubMed ID: 22968319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocator protein PET imaging for glial activation in multiple sclerosis.
    Oh U; Fujita M; Ikonomidou VN; Evangelou IE; Matsuura E; Harberts E; Fujimura Y; Richert ND; Ohayon J; Pike VW; Zhang Y; Zoghbi SS; Innis RB; Jacobson S
    J Neuroimmune Pharmacol; 2011 Sep; 6(3):354-61. PubMed ID: 20872081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
    Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
    Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-associated changes in longitudinal [
    De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
    Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.
    Narendran R; Lopresti BJ; Mason NS; Deuitch L; Paris J; Himes ML; Kodavali CV; Nimgaonkar VL
    J Neurosci; 2014 Jul; 34(30):9945-50. PubMed ID: 25057196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [
    Kim SW; Wiers CE; Tyler R; Shokri-Kojori E; Jang YJ; Zehra A; Freeman C; Ramirez V; Lindgren E; Miller G; Cabrera EA; Stodden T; Guo M; Demiral ŞB; Diazgranados N; Park L; Liow JS; Pike V; Morse C; Vendruscolo LF; Innis RB; Koob GF; Tomasi D; Wang GJ; Volkow ND
    Neuropsychopharmacology; 2018 Aug; 43(9):1832-1839. PubMed ID: 29777199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased hippocampal translocator protein (18 kDa) expression in alcohol dependence: a [
    Kalk NJ; Guo Q; Owen D; Cherian R; Erritzoe D; Gilmour A; Ribeiro AS; McGonigle J; Waldman A; Matthews P; Cavanagh J; McInnes I; Dar K; Gunn R; Rabiner EA; Lingford-Hughes AR
    Transl Psychiatry; 2017 Jan; 7(1):e996. PubMed ID: 28072413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects.
    Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Olgart Höglund C; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
    Brain Behav Immun; 2016 May; 54():149-157. PubMed ID: 26820224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.
    Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE
    Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.
    Van Weehaeghe D; Babu S; De Vocht J; Zürcher NR; Chew S; Tseng CJ; Loggia ML; Koole M; Rezaei A; Schramm G; Van Damme P; Hooker JM; Van Laere K; Atassi N
    J Nucl Med; 2020 Nov; 61(11):1621-1627. PubMed ID: 32169920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
    Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
    J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.